Clinical Trials Directory

Trials / Completed

CompletedNCT00897364

Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers

Analysis of Intermediate Endpoint Biomarkers in the Respiratory Epithelium of Smokers Compared to Non-Smoking Controls

Status
Completed
Phase
Study type
Observational
Enrollment
112 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

RATIONALE: Studying samples of tissue from smokers and non-smokers in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This phase II study is looking at biomarkers in the nose, throat, and lung tissue of smokers and non-smokers.

Detailed description

OBJECTIVES: Primary * Define the molecular and biochemical profiles of airway epithelium of smokers with no disease, smokers with airflow obstruction and abnormal sputum cytology, and non-smokers. Secondary * Assess the occurrence of abnormalities in non-smokers, smokers with no disease, smokers with various grades of dysplasia, and smokers with lung cancer. OUTLINE: Patients are stratified according to smoking status (smoker vs non-smoker) and disease (no disease vs airflow obstruction and abnormal sputum cytology vs various grades of dysplasia vs lung cancer). Biological samples are collected and analyzed for future research studies. PROJECTED ACCRUAL: A total of 78 patients will be accrued for this study.

Conditions

Timeline

Start date
2000-05-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2009-05-12
Last updated
2020-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00897364. Inclusion in this directory is not an endorsement.